You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Corynebacterium striatum prosthetic valve endocarditis with severe aortic regurgitation successfully treated with transcatheter aortic valve replacement

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Corynebacterium striatum prosthetic valve endocarditis with severe aortic regurgitation successfully treated with transcatheter aortic valve replacement
  1. Syed Yaseen Naqvi1,
  2. Ibrahim G Salama2,
  3. Craig Narins1 and
  4. Thomas Stuver1
  1. 1 Department of Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, New York, USA
  2. 2 Department of Internal Medicine, Unity Hospital, Rochester, New York, USA
  1. Correspondence to Dr Syed Yaseen Naqvi, syedalinaqvi1{at}gmail.com

Abstract

We describe the case of a 69-year-old man with a history of bioprosthetic aortic valve replacement who presented with Corynebacterium striatum prosthetic valve endocarditis (PVE) complicated by severe aortic insufficiency with refractory cardiogenic shock despite antibiotic therapy. He was considered a prohibitive-risk surgical candidate due to co-morbid conditions and off-label valve-in-valve transcatheter aortic valve replacement (TAVR) was performed after detailed multidisciplinary evaluation. He recovered well without recurrent infection following completion of antibiotics and transthoracic echocardiogram at 12 months showed a normal functioning prosthetic valve. To our knowledge, this is the first reported case of native or PVE treated with TAVR.

  • interventional cardiology
  • valvar diseases

https://doi.org/10.1136/bcr-2018-226881

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors SYN and IGS wrote the case. CN edited the case. TS edited the case and was the physician responsible for the patient care.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.